Last Updated : Jan 09, 2018 04:05 PM IST | Source: CNBC-TV18

Stay invested in Strides Shasun, says Sharmila Joshi

Sharmila Joshi of is of the view that one may stay invested in Strides Shasun.

CNBC TV18 @moneycontrolcom

Sharmila Joshi of told CNBC-TV18, "My advice on Strides Shasun is hold. They sold their India branded business to Eris Lifescience recently and they have sold another vertical indicating that they have taken sort of the issues on board and they are trying to sort of rebuild and rebrand their portfolio and hopefully that will yield results going ahead."

Strides Shasun ended at Rs 828.15, up Rs 0.10, or 0.01 percent on the BSE.
First Published on Jan 9, 2018 04:05 pm
Follow us on
Available On
PCI DSS Compliant